Latest / Clinical Guideline InSights
ASH Management of Relapsed/Refractory Disease in AYAs with Acute Lymphoblastic Leukemia – Overview
An update of the 2026 ASH Management of Relapsed/Refractory Disease in Adolescents and Young Adults with Acute Lymphoblastic Leukemia guideline, published by the American Society of Hematology on February 11, 2026.
Guideline Summary: https://www.guidelinecentral.com/guideline/5084999/
Full-Text: https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2021006479/566562/ASH-2026-Guidelines-for-Management-of-Relapsed
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.